Epitopea

Cambridge, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of transatlantic cancer immunotherapeutics designed to target a novel class of tumor-specific antigens. Epitopea is based in Cambridge, United Kingdom and was founded in 2021. It has raised $44.4 million.

Last price · $/share

—

Implied valuation

—

Total raised

$44.4M

Last round

—

How much has Epitopea raised?

$44.4Macross 0 recorded rounds

Free account

More of Epitopea with a free account

·The complete investor list: 15 names
·Watch Epitopea: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Epitopea investors

15 investors are on record for Epitopea, including Innovate UK, Investissement Quebec, Meltwind Advisory and Jonathan Milner.

For fundraisers

Raising for a company like Epitopea?

15 investors have backed Epitopea.

See all 15 investors →

Frequently asked about Epitopea

How much has Epitopea raised?: Epitopea has raised $44.4M in total across 0 recorded funding rounds.